org placeholder image

Chris Lawrence

VP, Drug Development at Neumedicines

  • LinkedIn

Email Email: c****@neumedicines.com

phone noPhone Number: (***)-***-****

o 25 years as a BioPharmaceutical Executive pioneering the Discovery, and Non-clinical and Clinical Development of Small Molecules and Biologicals.o 14 New Chemical Entities, Antibodies a...

Read More

map
NEUMEDICINES

NEUMEDICINES

  • description Description
    Neumedicines Inc. is an emerging therapeutic biotechnology company focused on developing and commercializing innovative and proprietary products and approaches that address unmet clinical and...

    Read More

  • Employees count Employees 11-50
  • Revenue Revenue 5 Million to 10 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Neumedicines Org Chart and Mapping

Employees

Rose Lopez

Sr. Director of Quality and Gmp Operations

David Morash

Member of Board of Directors

Frequently Asked Questions Regarding Chris Lawrence

Answer: Chris Lawrence works for Neumedicines as VP, Drug Development

Answer: Chris Lawrence’s role in Neumedicines is VP, Drug Development

Answer: Chris Lawrence's email address is c***@gmail.com

Answer: Chris Lawrence's business email address is c****@neumedicines.com

Answer: Chris Lawrence’s direct phone number is (***)-***-****

Answer: Chris Lawrence works in the industry of: Biotechnology

Answer: Chris Lawrence is the current VP, Drug Development at Neumedicines.... Read More

Answer: Chris Lawrence works Neumedicines located at 133 N Altadena Dr, Pasadena, California, 91107, United States

Answer: Neumedicines's VP, Drug Development is Chris Lawrence

Answer: Chris Lawrence contact details:

  • Phone number  :  (***)-***-****
  • Email  :  c****@neumedicines.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access